Gaynour B. G. Sletten
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gaynour B. G. Sletten has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Eliann Egaas
3 shared publicationsRagnhild Halvorsen
3 shared publicationsTrond S. Halstensen
3 shared publicationsE. Egaas
National Veterinary Institute , Oslo , Norway
1 shared publicationH.-J. Skarpeid
National Veterinary Institute , Oslo , Norway
1 shared publicationK. E. Løvberg
National Veterinary Institute , Oslo , Norway
1 shared publication
Latest Publications
- 7 February 2007
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 18 (1) , 71-80
Casein‐specific immunoglobulins in cow's milk allergic patient subgroups reveal a shift to IgA dominance in tolerant patients
Differences in casein‐specific immunoglobulin (Ig) G‐subclass and IgA serum levels between reactive and tolerant patients may hint at the immunopathogenesis during tolerance development in cow's milk allergy (CMA). α‐, β‐ and κ‐casein‐specific IgG1, IgG4, IgE and IgA serum levels were compared in clinically reactive and tolerized IgE‐mediated (n = 15) and non‐IgE‐mediated (n = 14) CMA with delayed gastrointestinal symptoms, using enzyme‐linked immunosorbent assay (ELISA) and immunoblot techniques. The median anti‐casein IgE levels in clinically reactive IgE‐mediated CMA patients (n = 9) were 140‐ to 180‐fold higher than in tolerized patients (n = 6) and 160‐ to 200‐fold higher than in controls (n = 10). Median α‐, β‐ and κ‐casein‐specific IgG1 and IgG4 levels were nine‐ to 60‐fold higher in reactive patients and five‐ to 60‐fold in tolerized patients. Clinical tolerance in IgE‐mediated CMA was thus associated with decreased casein‐specific IgE, IgG4 and IgG1, whereas serum IgA anti‐α ‐, β‐ and κ‐casein remained practically unaltered. Tolerized cow's milk protein (CMP)‐sensitive atopic dermatitis had, in particular, decreased κ‐casein‐specific IgG1 levels, compared with clinically reactive patients. The ELISA levels to immunoblot correlation profile for the α‐, β‐ and κ‐casein‐specific IgE suggested that the IgE‐mediated CMA patients predominantly reacted to tertiary α‐ and β‐casein epitopes whereas the IgE in non‐IgE‐mediated patients reacted to linearized α‐, β‐ and κ‐casein epitopes. Clinical tolerance in non‐IgE‐mediated CMA patients (n = 9) was associated with a four‐ to 10‐fold decrease in casein‐specific IgE levels, accompanied by a five‐ to eightfold decrease in IgG1 and five‐ to 60‐fold decrease in IgG4 levels, whereas casein‐specific IgA levels remained unaltered. Thus, tolerance in both patient groups was characterized by a generalized decreased humoral immune response to caseins, which induced a functional shift to IgA dominance.
- 7 February 2007
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 18 (1) , 71-80
Casein‐specific immunoglobulins in cow's milk allergic patient subgroups reveal a shift to IgA dominance in tolerant patients
Differences in casein‐specific immunoglobulin (Ig) G‐subclass and IgA serum levels between reactive and tolerant patients may hint at the immunopathogenesis during tolerance development in cow's milk allergy (CMA). α‐, β‐ and κ‐casein‐specific IgG1, IgG4, IgE and IgA serum levels were compared in clinically reactive and tolerized IgE‐mediated (n = 15) and non‐IgE‐mediated (n = 14) CMA with delayed gastrointestinal symptoms, using enzyme‐linked immunosorbent assay (ELISA) and immunoblot techniques. The median anti‐casein IgE levels in clinically reactive IgE‐mediated CMA patients (n = 9) were 140‐ to 180‐fold higher than in tolerized patients (n = 6) and 160‐ to 200‐fold higher than in controls (n = 10). Median α‐, β‐ and κ‐casein‐specific IgG1 and IgG4 levels were nine‐ to 60‐fold higher in reactive patients and five‐ to 60‐fold in tolerized patients. Clinical tolerance in IgE‐mediated CMA was thus associated with decreased casein‐specific IgE, IgG4 and IgG1, whereas serum IgA anti‐α ‐, β‐ and κ‐casein remained practically unaltered. Tolerized cow's milk protein (CMP)‐sensitive atopic dermatitis had, in particular, decreased κ‐casein‐specific IgG1 levels, compared with clinically reactive patients. The ELISA levels to immunoblot correlation profile for the α‐, β‐ and κ‐casein‐specific IgE suggested that the IgE‐mediated CMA patients predominantly reacted to tertiary α‐ and β‐casein epitopes whereas the IgE in non‐IgE‐mediated patients reacted to linearized α‐, β‐ and κ‐casein epitopes. Clinical tolerance in non‐IgE‐mediated CMA patients (n = 9) was associated with a four‐ to 10‐fold decrease in casein‐specific IgE levels, accompanied by a five‐ to eightfold decrease in IgG1 and five‐ to 60‐fold decrease in IgG4 levels, whereas casein‐specific IgA levels remained unaltered. Thus, tolerance in both patient groups was characterized by a generalized decreased humoral immune response to caseins, which induced a functional shift to IgA dominance.
- 13 November 2006
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 142 (3) , 190-198
Memory T Cell Proliferation in Cow’s Milk Allergy after CD25+ Regulatory T Cell Removal Suggests a Role for Casein-Specific Cellular Immunity in IgE-Mediated but Not in Non-IgE-Mediated Cow’s Milk Allergy
Background: Previously reported increased lymphocyte proliferative responses in cow’s milk allergy (CMA) may have been influenced by the lipopolysaccharides (LPS) which contaminate most commercial cow’s milk protein (CMPs). Moreover, peripheral blood mononuclear cells (PBMC) contain both B cells, CD45RA+ naïve T cells, CD25+ regulatory T cells (Tregs) in addition to antigen-specific CD45RA– memory T cells. Methods: PBMC from clinically reactive and tolerised patients with IgE- and non-IgE-mediated CMA were depleted of CD45RA+ T cells and putative CD25+ Tregs. The proliferative index to LPS-depleted α-, β- and ĸ-casein and β-lactoglobulin was compared in the memory T-cell-enriched, Treg-depleted PBMC and in bulk PBMC. Results: Clinically reactive IgE-mediated CMA patients had increased responses to caseins only. Tolerised patients, particularly those with atopic dermatitis, had decreased responses to ĸ-casein which were restored after Treg depletion. Interleukin-4 and interferon-γ were generally not detected in the culture supernatants. No differences were seen between reactive and tolerant delayed non-IgE-mediated CMA patients. Conclusions: Proliferative responses to α-, β- and ĸ-caseins (but not β-lactoglobulin) were observed in clinically reactive IgE-mediated CMA patients only. A markedly decreased proliferative response to ĸ-casein in tolerised IgE-mediated CMA patients with atopic dermatitis, which was abrogated by Treg depletion, suggested a role for ĸ-casein in tolerance induction. Non-IgE-mediated CMA patients had no increased proliferative response to any milk proteins.
- 13 November 2006
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 142 (3) , 190-198
Memory T Cell Proliferation in Cow’s Milk Allergy after CD25+ Regulatory T Cell Removal Suggests a Role for Casein-Specific Cellular Immunity in IgE-Mediated but Not in Non-IgE-Mediated Cow’s Milk Allergy
Background: Previously reported increased lymphocyte proliferative responses in cow’s milk allergy (CMA) may have been influenced by the lipopolysaccharides (LPS) which contaminate most commercial cow’s milk protein (CMPs). Moreover, peripheral blood mononuclear cells (PBMC) contain both B cells, CD45RA+ naïve T cells, CD25+ regulatory T cells (Tregs) in addition to antigen-specific CD45RA– memory T cells. Methods: PBMC from clinically reactive and tolerised patients with IgE- and non-IgE-mediated CMA were depleted of CD45RA+ T cells and putative CD25+ Tregs. The proliferative index to LPS-depleted α-, β- and ĸ-casein and β-lactoglobulin was compared in the memory T-cell-enriched, Treg-depleted PBMC and in bulk PBMC. Results: Clinically reactive IgE-mediated CMA patients had increased responses to caseins only. Tolerised patients, particularly those with atopic dermatitis, had decreased responses to ĸ-casein which were restored after Treg depletion. Interleukin-4 and interferon-γ were generally not detected in the culture supernatants. No differences were seen between reactive and tolerant delayed non-IgE-mediated CMA patients. Conclusions: Proliferative responses to α-, β- and ĸ-caseins (but not β-lactoglobulin) were observed in clinically reactive IgE-mediated CMA patients only. A markedly decreased proliferative response to ĸ-casein in tolerised IgE-mediated CMA patients with atopic dermatitis, which was abrogated by Treg depletion, suggested a role for ĸ-casein in tolerance induction. Non-IgE-mediated CMA patients had no increased proliferative response to any milk proteins.
- 17 May 2006
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 17 (6) , 435-443
Changes in humoral responses to β‐lactoglobulin in tolerant patients suggest a particular role for IgG4 in delayed, non‐IgE‐mediated cow's milk allergy
The major cow's milk allergen β‐lactoglobulin (β‐LG) is relatively resistant to enzymatic degradation and may therefore be involved in non‐immunoglobulin (Ig)E‐mediated cow's milk allergy (CMA) with delayed gastrointestinal symptoms. Serum levels of β‐LG‐specific IgG1, IgG4, IgE, and IgA were compared in clinically reactive and tolerized IgE‐mediated and non‐IgE‐mediated CMA with delayed gastrointestinal symptoms (n = 29) and controls (n = 10). Tolerance was associated with decreased β‐LG‐specific IgE, IgG1, and IgG4 levels in both patient groups. However, the significantly increased β‐LG‐specific IgG4 levels in clinically reactive non‐IgE‐mediated CMA patients, and its median 36‐fold reduction in tolerant patients, suggested a possible immunopathological role for IgG4 in delayed CMA. Similarly, the significantly increased β‐LG‐specific IgE levels in IgE‐mediated CMA patients were decreased 44‐fold in tolerant patients. The tolerant patients had apparently shifted the humoral immune response from a β‐LG‐specific IgE‐ and/or IgG4‐dominated immune response to an IgA‐dominated immune response as the IgA/IgE or IgA/IgG4 ratios increased 90‐ and 15‐fold in tolerant IgE‐mediated‐, and non‐IgE‐mediated CMA patients, respectively. Thus, the marked difference in β‐LG‐specific Ig ratios suggested a tolerance‐induced inhibition of a Th2‐type of immune response with significantly increased IgA dominance in both CMA patient groups.
- 17 May 2006
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 17 (6) , 435-443
Changes in humoral responses to β‐lactoglobulin in tolerant patients suggest a particular role for IgG4 in delayed, non‐IgE‐mediated cow's milk allergy
The major cow's milk allergen β‐lactoglobulin (β‐LG) is relatively resistant to enzymatic degradation and may therefore be involved in non‐immunoglobulin (Ig)E‐mediated cow's milk allergy (CMA) with delayed gastrointestinal symptoms. Serum levels of β‐LG‐specific IgG1, IgG4, IgE, and IgA were compared in clinically reactive and tolerized IgE‐mediated and non‐IgE‐mediated CMA with delayed gastrointestinal symptoms (n = 29) and controls (n = 10). Tolerance was associated with decreased β‐LG‐specific IgE, IgG1, and IgG4 levels in both patient groups. However, the significantly increased β‐LG‐specific IgG4 levels in clinically reactive non‐IgE‐mediated CMA patients, and its median 36‐fold reduction in tolerant patients, suggested a possible immunopathological role for IgG4 in delayed CMA. Similarly, the significantly increased β‐LG‐specific IgE levels in IgE‐mediated CMA patients were decreased 44‐fold in tolerant patients. The tolerant patients had apparently shifted the humoral immune response from a β‐LG‐specific IgE‐ and/or IgG4‐dominated immune response to an IgA‐dominated immune response as the IgA/IgE or IgA/IgG4 ratios increased 90‐ and 15‐fold in tolerant IgE‐mediated‐, and non‐IgE‐mediated CMA patients, respectively. Thus, the marked difference in β‐LG‐specific Ig ratios suggested a tolerance‐induced inhibition of a Th2‐type of immune response with significantly increased IgA dominance in both CMA patient groups.
- Open Access
- 1 September 2005
- Published by Taylor & Francis in Food and Agricultural Immunology
- Vol. 16 (3) , 235-243
A comparison of time-resolved fluoroimmunoassay and ELISA in the detection of casein in foodstuffs
With the aim of lowering the detection limit for casein in foods, three competitive assays are described: direct time-resolved fluoroimmunoassay (TR-FIA), using europium-conjugated antibody, indirect TR-FIA, using biotinylated antibody with europium-conjugated streptavidin and ELISA, using a HRP-conjugated secondary antibody. Food samples (instant potato, flour mix, packet soup, spice-mix) were analysed. Standard curve sensitivities in direct and indirect TR-FIAs did not differ significantly (p=0.097), but both TR-FIAs were considerably less sensitive (both p−1, respectively). The precision and working analyte range was similar in all three methods. Casein content measured in food products was comparable, using the three assays and rocket immunoelectrophoresis. The TR-FIA approach provided no improvement over the ELISA. All three assays allowed quantification of casein in foodstuffs in the order of 1–1.5 mg kg−1, providing a basis for more rigorous validation and collaborative testing.
- 1 September 2005
- Published by Taylor & Francis in Food and Agricultural Immunology
- Vol. 16 (3) , 235-243
Open AccessA comparison of time-resolved fluoroimmunoassay and ELISA in the detection of casein in foodstuffs
With the aim of lowering the detection limit for casein in foods, three competitive assays are described: direct time-resolved fluoroimmunoassay (TR-FIA), using europium-conjugated antibody, indirect TR-FIA, using biotinylated antibody with europium-conjugated streptavidin and ELISA, using a HRP-conjugated secondary antibody. Food samples (instant potato, flour mix, packet soup, spice-mix) were analysed. Standard curve sensitivities in direct and indirect TR-FIAs did not differ significantly (p=0.097), but both TR-FIAs were considerably less sensitive (both p−1, respectively). The precision and working analyte range was similar in all three methods. Casein content measured in food products was comparable, using the three assays and rocket immunoelectrophoresis. The TR-FIA approach provided no improvement over the ELISA. All three assays allowed quantification of casein in foodstuffs in the order of 1–1.5 mg kg−1, providing a basis for more rigorous validation and collaborative testing.